nGEN Pump
Biosense Webster, Inc. · Decision date Dec 23, 2025
What did the FDA approve?
FDA records P990071/S068 as a supplement to PMA P990071, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Dec 23, 2025.
FDA approval order statement
a software update to the TRUPULSE Generator and an update to the user manual of the nGEN Pump to facilitate automatic delivery of irrigation at 30 mL/min upon initiation of energy delivery
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Dec 23, 2025
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P990071/S068
- Regulatory pathway
- PMA supplement
- Applicant
- Biosense Webster, Inc.
- Product code
- LPB
- Decision code
- APPR
- Decision date
- Dec 23, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Cardiac ablation percutaneous catheter.
- Applicant
- Biosense Webster, Inc.
- Product code
- LPB
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P990071/S067 · Related supplement
SMARTABLATE System Interface Cable (D-1303-02-S)
P990071/S068 received
Application receipt date recorded by FDA.
P990071/S068 · FDA decision
Real-Time Process
Timeline entries are records held by MedtechLedger for P990071. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P990071
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
SMARTABLATE System Interface Cable (D-1303-02-S)P990071/S067 | Biosense Webster, Inc. | PMA supplement | Sep 15, 2025 | FDA |
Explore the linked device profile
Other records with product code LPB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biosense Webster, Inc. | PMA supplement | Sep 15, 2026 | FDA | |
| Irvine Biomedical, Inc. | PMA supplement | Sep 3, 2026 | FDA | |
Ampere GeneratorP040014/S051 | Irvine Biomedical, Inc. | PMA supplement | Aug 7, 2026 | FDA |
Ampere GeneratorP960016/S094 | St Jude Medical | PMA supplement | Aug 7, 2026 | FDA |
MAGiC Ablation CatheterP240014/S001 | Stereotaxis, Inc. | PMA supplement | Jul 31, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Biosense Webster, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 31 Technology Dr., Suite 200, Irvine, CA, 92618
Sources and methodology
- Original FDA record: P990071/S068
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


